World Sleep Industry ENCYCLOPEDIA

Sleep Animal Experiment Services

6.5.3

Definition, scope, and responsibility boundary

Sleep animal experiment services are commissioned research activities in which a team with appropriate facilities, personnel, and approvals uses animal models to investigate sleep–wake states, circadian rhythms, breathing, neural activity, metabolism, behavior, or responses to interventions. Services may include study design, model and measurement selection, ethics materials, acclimation, surgical and recording support, interventions, specimen and data collection, analysis, and reporting. Animal care, veterinary judgment, institutional oversight, and investigator accountability cannot be outsourced out of existence. A contract, facility quotation, or client approval does not replace required project and institutional authorization.

The provider should state the species, procedures, severity levels, equipment, barrier conditions, staff qualifications, veterinary coverage, and quality system it can support and distinguish exploratory, mechanistic, efficacy, safety, and regulatory work. Animal findings may inform biological mechanisms or later research decisions but do not directly establish human safety, clinical effectiveness, diagnostic performance, or market authorization. The sponsor and performing organization should allocate in advance authority for protocol amendments, animal-welfare actions, deviations, serious adverse events, data interpretation, publication, and study stopping.

Scientific necessity, the 3Rs, and ethical approval

Planning should begin with review of existing evidence and an explanation of why cells, organoids, computational models, public data, human samples, or other non-animal approaches cannot adequately answer the question. Animals should not be used where replacement is feasible. Where complete replacement is not possible, a reliable design should obtain the needed information without underpowered or purposeless repetition, reducing numbers, while gentler sampling, noninvasive or longitudinal measurement, environmental improvement, and care refinement minimize pain, distress, and lasting harm. Replacement, reduction, and refinement require auditable actions, not a generic statement.

Before work begins, every procedure requires the applicable ethics or animal-care-and-use review covering scientific purpose, animal choice, number justification, expected benefit, severity, anesthesia and analgesia, monitoring, humane endpoints, euthanasia, and final disposition. Approval should correspond to the actual site, personnel, and procedures; interinstitutional transfer, outsourcing, or a protocol change may require amendment or renewed approval. A study must not increase deprivation duration, stimulus intensity, sampling frequency, or survival surgery after approval without authorization, and retrospective ethics filing after experiments is not acceptable.

Model selection, animal characteristics, and environmental control

Model selection should follow the question and explain how species, strain, genetic background, sex, age, weight, health status, and previous procedures relate to the target mechanism. Source, quarantine, acclimation, and eligibility criteria should be specified. Investigators should consider whether sex, life stage, and comorbidity alter the sleep phenotype and justify a single sex, strain, or model where used. If a model is unstable, causes excessive mortality, or fails to produce its prespecified phenotype, predefined review or stopping rules should apply instead of continually adding animals until a positive result appears.

Light–dark cycle, intensity and spectrum, temperature, humidity, noise, vibration, cage position, group or individual housing, bedding, nesting, enrichment, feeding, cage changes, handling, and experimental time can alter sleep, stress, and circadian rhythms. The protocol should record room and cage conditions, phase transitions, and unintended light exposure and balance cage position, operator, and time across groups where possible. When tethers, implants, or interventions alter social or environmental conditions, welfare and scientific confounding should be assessed, with species-appropriate recovery, shelter, and thermoregulation provided.

Experimental design and bias control

The design should define whether the experimental unit is the animal, cage, litter, or another unit; distinguish biological from technical replicates; and specify the primary outcome, effect size, variance, significance level, power, and sample-size rationale. Group sizes should be neither conveniently underpowered nor inflated on the theory that more is always safer. Repeated measures, crossover designs, or multimodal collection from the same animal may increase information, but order, carryover, clustering, and welfare burden must be addressed, and multiple time points must not be counted as independent animals.

Random allocation, allocation concealment, masking during intervention, outcome scoring, and analysis should be planned and recorded to the extent feasible; reasons and alternative controls should be given when masking is impossible. Sex, age, baseline sleep, weight, cage position, surgical batch, recording order, and circadian phase should be balanced or stratified as potential confounders. Eligibility, artifact, implant-failure, mortality, missingness, and outlier rules should be fixed before unmasking, with all animal flow reported by group. Deviations, null results, and unfavorable findings must not be selectively removed.

Procedures, monitoring, and humane endpoints

Anesthesia, surgery, electrode or catheter implantation, dosing, blood sampling, and other invasive work should be performed by competent personnel with aseptic practice and veterinary support, using anesthesia, analgesia, and perioperative care appropriate to the species and procedure. Records should cover anesthetic depth, temperature, vital signs, recovery, wounds, weight, intake, activity, and pain indicators, with contingencies for equipment failure and emergencies. If analgesia may influence sleep outcomes, the design should control and interpret that effect; necessary pain relief must not be withheld without approved scientific justification merely to obtain cleaner data.

Sleep restriction, fragmentation, forced activity, altered lighting, and breathing-related models may affect stress, temperature, feeding, and movement as well as sleep. Appropriate controls should distinguish the target sleep effect from nonspecific effects of the procedure. Monitoring frequency and humane endpoints should match expected severity. When prespecified indicators of pain, debility, wounds, weight change, inability to eat or drink, or other welfare problems occur, authorized personnel should treat, pause, withdraw, or euthanize the animal. Death should not be an endpoint when an earlier clinical indicator can be used, and euthanasia requires competent performance and confirmation of death.

Sleep recording, scoring, and analysis

Sleep may be measured with electroencephalography and electromyography, video, activity, temperature, respiration, oxygen saturation, metabolism, or other signals, according to species, model, and question. Electrode placement, reference, hardware, sampling rate, filters, synchronization, calibration, recording duration, light–dark phase, and artifact rules should be fixed, and raw data retained. Rodent studies commonly distinguish wake, non-rapid-eye-movement sleep, and rapid-eye-movement sleep, but no single scoring manual applies unconditionally across every species, age, disease, and device. Frequency bands, epochs, and transition rules require explicit definition.

Automated scoring should document training data, version, thresholds, human review, and performance and be validated in the target animals and signal configuration; drift should be assessed after software updates. Primary outcomes may include state duration, architecture, transitions, fragmentation, latency, spectra, or respiratory events, with denominators and time windows defined in the protocol. Analysis should address within-animal repetition, cage or litter clustering, circadian phase, missingness, and multiplicity and report effect sizes and uncertainty. Association or an intervention effect in a model must not be directly extrapolated into a human treatment conclusion.

Delivery, quality, and study closeout

The delivery package should contain the approved protocol and amendments, randomization and masking records, animal identities and characteristics, husbandry and environmental logs, procedure records, welfare and veterinary records, deviations, raw data, data dictionary, analysis code, statistical output, and complete report. Transparent reporting should identify the experimental unit, sample-size rationale, every inclusion and exclusion, actual group counts, methods, limitations, and 3R measures and separate prespecified from exploratory findings. Images, traces, and representative excerpts cannot replace the complete data, and labels such as “ethically compliant” or “high-quality model” cannot excuse missing records.

Quality oversight should include staff training, equipment maintenance and calibration, traceability of drugs and materials, source-record audit, data backup, corrective and preventive action, and escalation of welfare incidents. At closeout, humane disposition, specimen custody, archiving, access revocation, and arrangements for remaining animals should follow the approved plan, with consideration of sharing null findings, tissues, or data to reduce duplicate use. Quality is measured by scientific necessity, implemented 3Rs, protected welfare, robust design, traceable records, and restrained interpretation—not by animal numbers, positive findings, or delivery speed.